136 related articles for article (PubMed ID: 36396515)
21. Killer Ig-like receptor ligand mismatch directs NK cell expansion in vitro.
Rose MJ; Brooks AG; Stewart LA; Nguyen TH; Schwarer AP
J Immunol; 2009 Oct; 183(7):4502-8. PubMed ID: 19748981
[TBL] [Abstract][Full Text] [Related]
22. [Differential expression levels of killer immunoglobin-like receptor genotype in patients with hematological malignancies between high-risk and standard-risk groups].
Zhao XY; Chang YJ; Huang XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):746-9. PubMed ID: 18718052
[TBL] [Abstract][Full Text] [Related]
23.
Liu LL; Béziat V; Oei VYS; Pfefferle A; Schaffer M; Lehmann S; Hellström-Lindberg E; Söderhäll S; Heyman M; Grandér D; Malmberg KJ
Cancer Immunol Res; 2017 Aug; 5(8):654-665. PubMed ID: 28637877
[TBL] [Abstract][Full Text] [Related]
24. Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT.
Mansouri M; Villard J; Ramzi M; Alavianmehr A; Farjadian S
Hum Immunol; 2020 Jun; 81(6):285-292. PubMed ID: 32199702
[TBL] [Abstract][Full Text] [Related]
25. Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells.
Igarashi T; Wynberg J; Srinivasan R; Becknell B; McCoy JP; Takahashi Y; Suffredini DA; Linehan WM; Caligiuri MA; Childs RW
Blood; 2004 Jul; 104(1):170-7. PubMed ID: 15016654
[TBL] [Abstract][Full Text] [Related]
26. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.
Boissel L; Tuncer HH; Betancur M; Wolfberg A; Klingemann H
Biol Blood Marrow Transplant; 2008 Sep; 14(9):1031-1038. PubMed ID: 18721766
[TBL] [Abstract][Full Text] [Related]
27. Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood.
Della Chiesa M; Falco M; Bertaina A; Muccio L; Alicata C; Frassoni F; Locatelli F; Moretta L; Moretta A
J Immunol; 2014 Feb; 192(4):1471-9. PubMed ID: 24442432
[TBL] [Abstract][Full Text] [Related]
28. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity.
Pende D; Marcenaro S; Falco M; Martini S; Bernardo ME; Montagna D; Romeo E; Cognet C; Martinetti M; Maccario R; Mingari MC; Vivier E; Moretta L; Locatelli F; Moretta A
Blood; 2009 Mar; 113(13):3119-29. PubMed ID: 18945967
[TBL] [Abstract][Full Text] [Related]
29. IL-12 directs further maturation of ex vivo differentiated NK cells with improved therapeutic potential.
Lehmann D; Spanholtz J; Sturtzel C; Tordoir M; Schlechta B; Groenewegen D; Hofer E
PLoS One; 2014; 9(1):e87131. PubMed ID: 24498025
[TBL] [Abstract][Full Text] [Related]
30. The role of KIR positive NK cells in diseases and its importance in clinical intervention.
Dizaji Asl K; Velaei K; Rafat A; Tayefi Nasrabadi H; Movassaghpour AA; Mahdavi M; Nozad Charoudeh H
Int Immunopharmacol; 2021 Mar; 92():107361. PubMed ID: 33429335
[TBL] [Abstract][Full Text] [Related]
31. The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors.
de Rham C; Ferrari-Lacraz S; Jendly S; Schneiter G; Dayer JM; Villard J
Arthritis Res Ther; 2007; 9(6):R125. PubMed ID: 18053164
[TBL] [Abstract][Full Text] [Related]
32. New insights on the natural killer cell repertoire from a thorough analysis of cord blood cells.
Rettman P; Willem C; David G; Riou R; Legrand N; Esbelin J; Cesbron A; Senitzer D; Gagne K; Retière C
J Leukoc Biol; 2016 Sep; 100(3):471-9. PubMed ID: 27067451
[TBL] [Abstract][Full Text] [Related]
33. Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation.
Zhou H; Bao X; Wu X; Tang X; Wang M; Wu D; He J
Biol Blood Marrow Transplant; 2014 Jan; 20(1):98-105. PubMed ID: 24516895
[TBL] [Abstract][Full Text] [Related]
34. Cord blood derived NK cells activated in counter with tumor cells.
Valipour B; Majidi G; Dizaji Asl K; Nozad Charoudeh H
Cell Tissue Bank; 2023 Sep; 24(3):551-560. PubMed ID: 36456837
[TBL] [Abstract][Full Text] [Related]
35. Next-generation sequencing technology a new tool for killer cell immunoglobulin-like receptor allele typing in hematopoietic stem cell transplantation.
Maniangou B; Retière C; Gagne K
Transfus Clin Biol; 2018 Feb; 25(1):87-89. PubMed ID: 29032017
[TBL] [Abstract][Full Text] [Related]
36. Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions.
Kopp LM; Ray A; Denman CJ; Senyukov VS; Somanchi SS; Zhu S; Lee DA
Mol Immunol; 2013 Jul; 54(3-4):296-301. PubMed ID: 23328088
[TBL] [Abstract][Full Text] [Related]
37. How important is NK alloreactivity and KIR in allogeneic transplantation?
Shaffer BC; Hsu KC
Best Pract Res Clin Haematol; 2016 Dec; 29(4):351-358. PubMed ID: 27890259
[TBL] [Abstract][Full Text] [Related]
38. Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation.
Vago L; Forno B; Sormani MP; Crocchiolo R; Zino E; Di Terlizzi S; Lupo Stanghellini MT; Mazzi B; Perna SK; Bondanza A; Middleton D; Palini A; Bernardi M; Bacchetta R; Peccatori J; Rossini S; Roncarolo MG; Bordignon C; Bonini C; Ciceri F; Fleischhauer K
Blood; 2008 Oct; 112(8):3488-99. PubMed ID: 18645039
[TBL] [Abstract][Full Text] [Related]
39. Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells.
Romagné F; André P; Spee P; Zahn S; Anfossi N; Gauthier L; Capanni M; Ruggeri L; Benson DM; Blaser BW; Della Chiesa M; Moretta A; Vivier E; Caligiuri MA; Velardi A; Wagtmann N
Blood; 2009 Sep; 114(13):2667-77. PubMed ID: 19553639
[TBL] [Abstract][Full Text] [Related]
40. Genetic and Molecular Basis of Heterogeneous NK Cell Responses against Acute Leukemia.
Makanga DR; Da Rin de Lorenzo F; David G; Willem C; Dubreuil L; Legrand N; Guillaume T; Peterlin P; Lebourgeois A; Béné MC; Garnier A; Chevallier P; Gendzekhadze K; Cesbron A; Gagne K; Clemenceau B; Retière C
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
